Skip to main content

Advertisement

SpringerLink
Log in

Assisted Reproductive Technologies and Their Association With Adverse Pregnancy Outcomes and Long-Term Cardiovascular Disease: Implications for Counseling Patients

  • Reproductive Health and Cardiovascular Disease (G Sharma, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose of review

Assisted reproductive technology (ART) has continued to emerge as a treatment option for infertility, a condition that affects a significant proportion of couples of reproductive age. The goal of this review is to provide information on the link between adverse pregnancy outcomes (APOs) and ART and long-term cardiovascular consequences associated with these therapies.

Recent findings

Increasing use and advancing maternal age have raised concerns regarding the short- and long-term use of such technologies. ART and associated hormonal therapies are known to cause potential vascular effects and have an association with APOs and cardiovascular disease.

Summary

Our review highlights potential risks associated with ART and the need for pre-treatment awareness and counseling of short-term APO risk and long-term cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113(3):533–5. https://doi.org/10.1016/j.fertnstert.2019.11.025.

    Article  Google Scholar 

  2. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44–50. https://doi.org/10.1016/j.fertnstert.2015.03.019.

    Article  Google Scholar 

  3. Infertility workup for the women’s health specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol. 2019;133(6):e377–e84. https://doi.org/10.1097/AOG.0000000000003271.

  4. Eskew AM, Jungheim ES. A history of developments to improve in vitro fertilization. Mo Med. 2017;114(3):156–9.

    PubMed  PubMed Central  Google Scholar 

  5. Sunderam S, Kissin DM, Crawford SB, Folger SG, Boulet SL, Warner L, et al. Assisted reproductive technology surveillance - United States, 2015. MMWR Surveill Summ. 2018;67(3):1–28. https://doi.org/10.15585/mmwr.ss6703a1.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Luke B, Brown MB, Eisenberg ML, Callan C, Botting BJ, Pacey A, et al. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters. Am J Obstet Gynecol. 2020;222(4):350 e1–e13. https://doi.org/10.1016/j.ajog.2019.10.003.

    Article  Google Scholar 

  7. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786–801. https://doi.org/10.1093/humrep/dex234.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the Society of Reproductive Biologists and Technologists. Minimum standards for practices offering assisted reproductive technologies: a committee opinion. Fertil Steril. 2020;113(3):536–41. https://doi.org/10.1016/j.fertnstert.2019.11.024.

    Article  Google Scholar 

  9. Society for Assisted Reproductive Technology. Assisted reproductive technologies. Available at: https://www.sart.org/patients/a-patients-guide-to-assisted-reproductive-technology/general-information/assisted-reproductive-technologies/. Accessed Feb 12, 2021.

  10. Perinatal risks associated with assisted reproductive technology: ACOG Committee Opinion, number 671. Obstet Gynecol. 2016;128(3):e61–8. https://doi.org/10.1097/AOG.0000000000001643.

  11. Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73–85 e1–6. https://doi.org/10.1016/j.fertnstert.2015.09.007. The paper provides a comprehensive and detailed review of the utilization of ART and the major maternal and fetal risks of the most used forms of ART such as fresh IVF, donor egg IVF, and frozen embryo transfer. Subfertility, with or without IVF or other infertility treatments to achieve pregnancy, is associated with increased risks of adverse maternal and perinatal outcomes. The lingering question is whether the adverse outcomes are related to something specific with infertility or the type of ART process.

  12. Zhu L, Zhang Y, Liu Y, Zhang R, Wu Y, Huang Y, et al. Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: a retrospective cohort study. Sci Rep. 2016;6:35141. https://doi.org/10.1038/srep35141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217(3):270–81. https://doi.org/10.1016/j.ajog.2017.03.012.

    Article  PubMed  Google Scholar 

  14. von Versen-Hoynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis M, et al. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73(3):640–9. https://doi.org/10.1161/HYPERTENSIONAHA.118.12043.

    Article  CAS  Google Scholar 

  15. Conrad KP, Petersen JW, Chi YY, Zhai X, Li M, Chiu KH, et al. Maternal cardiovascular dysregulation during early pregnancy after in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;74(3):705–15. https://doi.org/10.1161/HYPERTENSIONAHA.119.13015. This prospective observational study compared changes in early pregnancy cardiovascular function and responses in 3 groups—spontaneous conceptions with a single CL, ovum donation IVF pregnancies without a CL and IVF pregnancies with multiple CLs. The findings support the assertion that the higher risk of preeclampsia is related to poorer early pregnancy cardiovascular adaptation. The study supports the concept that CL factors may directly influence early pregnancy maternal cardiovascular adaptation, or to seek to determine if the observed cardiovascular derangements may also have predated the development of the CL.

  16. Ginstrom Ernstad E, Bergh C, Khatibi A, Kallen KB, Westlander G, Nilsson S, et al. Neonatal and maternal outcome after blastocyst transfer: a population-based registry study. Am J Obstet Gynecol. 2016;214(3):378 e1–e10. https://doi.org/10.1016/j.ajog.2015.12.040.

    Article  Google Scholar 

  17. Centers for Disease Control and Prevention. 2018 Assisted reproductive technology fertility clinic success rates report. Atlanta: US Dept of Health and Human Services; 2020. Available at: https://www.cdc.gov/art/reports/2018/fertility-clinic.html. Accessed Feb 12, 2021

    Google Scholar 

  18. Rossberg N, Stangl K, Stangl V. Pregnancy and cardiovascular risk: a review focused on women with heart disease undergoing fertility treatment. Eur J Prev Cardiol. 2016;23(18):1953–61. https://doi.org/10.1177/2047487316673143.

    Article  PubMed  Google Scholar 

  19. Manau D, Balasch J, Arroyo V, Jiménez W, Fábregues F, Casamitjana R, et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab. 1998;83(5):1489–93. https://doi.org/10.1210/jcem.83.5.4796.

    Article  CAS  PubMed  Google Scholar 

  20. Farquhar C, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018;8(8):Cd010537. https://doi.org/10.1002/14651858.CD010537.pub5.

    Article  PubMed  Google Scholar 

  21. Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril. 1995;63(2):268–72. https://doi.org/10.1016/s0015-0282(16)57353-1.

    Article  CAS  PubMed  Google Scholar 

  22. Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634–47. https://doi.org/10.1016/j.fertnstert.2016.08.048.

    Article  Google Scholar 

  23. Al-Sadawi M, Chowdhury R, Asun S, Ray J, Soni L, Bahtiyar G, et al. Ovarian hyperstimulation syndrome and myocardial infarction: a systematic review. Int J Clin Endocrinol Metab. 2019;5(1):009–12. https://doi.org/10.17352/ijcem.000035.

    Article  PubMed  Google Scholar 

  24. Pepine CJ, Park K. Fertility therapy and long-term cardiovascular risk: raising more questions than answers?∗. J Am Coll Cardiol. 2017;70(10):1214–5. https://doi.org/10.1016/j.jacc.2017.07.731.

    Article  PubMed  Google Scholar 

  25. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27(2–3):121–8. https://doi.org/10.1007/s10815-010-9387-6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Fernandez LA, Tarlatzis BC, Rzasa PJ, Caride VJ, Laufer N, Negro-Vilar AF, et al. Renin-like activity in ovarian follicular fluid. Fertil Steril. 1985;44(2):219–23. https://doi.org/10.1016/s0015-0282(16)48740-6.

    Article  CAS  PubMed  Google Scholar 

  27. Manno M, Tomei F. Renin-angiotensin system activation during severe OHSS: cause or effect? Fertil Steril. 2008;2. United States:488.

  28. Kametas NA, McAuliffe F, Krampl E, Chambers J, Nicolaides KH. Maternal cardiac function in twin pregnancy. Obstet Gynecol. 2003;102(4):806–15. https://doi.org/10.1016/s0029-7844(03)00807-x.

    Article  PubMed  Google Scholar 

  29. Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148–57. https://doi.org/10.1038/jhh.2012.13.

    Article  CAS  PubMed  Google Scholar 

  30. Almasi-Hashiani A, Omani-Samani R, Mohammadi M, Amini P, Navid B, Alizadeh A, et al. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):149. https://doi.org/10.1186/s12884-019-2291-x.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T, et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–13. https://doi.org/10.1016/j.jacc.2017.07.753. Dayan et al. present a systematic review of the very limited data on the risk of CV events after exposure to fertility therapy assessing only 6 observational studies consisting of just over 40,000 women who received fertility therapy. The authors found an increased incidence of adverse pregnancy outcomes without an increase in CV events among women exposed to fertility therapy.

  32. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100. https://doi.org/10.1016/j.fertnstert.2011.10.038.

    Article  PubMed  Google Scholar 

  33. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod. 1997;12(10):2167–73. https://doi.org/10.1093/humrep/12.10.2167.

    Article  CAS  PubMed  Google Scholar 

  34. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082–e143. https://doi.org/10.1161/cir.0000000000000625.

    Article  PubMed  Google Scholar 

  35. Park K, Wei J, Minissian M, Bairey Merz CN, Pepine CJ. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child. Cardiovasc Drugs Ther. 2015;29(4):391–401. https://doi.org/10.1007/s10557-015-6597-2.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dayan N, Laskin CA, Spitzer K, Mason J, Udell JA, Wald RM, et al. Pregnancy complications in women with heart disease conceiving with fertility therapy. J Am Coll Cardiol. 2014;64(17):1862–4. https://doi.org/10.1016/j.jacc.2014.07.977.

    Article  PubMed  Google Scholar 

  37. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97. https://doi.org/10.1093/eurheartj/ehr218.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL, 32610, USA

    Ki Park MD

  2. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, FL, USA

    Emily Allard-Phillips MD, Gregory Christman MD & Alice Rhoton-Vlasak MD

  3. Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA

    Michelle Dimza MD

Authors
  1. Ki Park MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily Allard-Phillips MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregory Christman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michelle Dimza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alice Rhoton-Vlasak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ki Park MD.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Ki Park, Emily Allard-Phillips, Gregory Christman, Michelle Dimza, and Alice Rhoton-Vlasak declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Reproductive Health and Cardiovascular Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, K., Allard-Phillips, E., Christman, G. et al. Assisted Reproductive Technologies and Their Association With Adverse Pregnancy Outcomes and Long-Term Cardiovascular Disease: Implications for Counseling Patients. Curr Treat Options Cardio Med 23, 54 (2021). https://doi.org/10.1007/s11936-021-00932-3

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11936-021-00932-3

Keywords

Search

Navigation